Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science